Article
A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.
Respiratory medicine - 1 Jan 2026
Zhang Shi-Ming, Huang Mei-Zhen, Wang Yi-Wen, Wang Xiao-Fei, Ding Yan, Li Jia-Min, Zou Xiao-Mei, Ma Cheng-Yao
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterised by irreversible fibrotic remodelling and a poor prognosis. The typical survival rate is 3-5 years after diagnosis. Although considerable progress has been made in understanding its underlying biology, early detection remains difficult and available treatments provide only limited benefit. Current evidence points...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
